Viewing Study NCT03422094


Ignite Creation Date: 2025-12-25 @ 1:43 AM
Ignite Modification Date: 2025-12-26 @ 12:01 AM
Study NCT ID: NCT03422094
Status: TERMINATED
Last Update Posted: 2021-10-27
First Post: 2018-01-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Neoantigen-based Personalized Vaccine Combined With Immune Checkpoint Blockade Therapy in Patients With Newly Diagnosed, Unmethylated Glioblastoma
Sponsor: Washington University School of Medicine
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2018-10-31
Start Date Type: ACTUAL
Primary Completion Date: 2020-04-26
Primary Completion Date Type: ACTUAL
Completion Date: 2020-12-31
Completion Date Type: ACTUAL
First Submit Date: 2018-01-29
First Submit QC Date: None
Study First Post Date: 2018-02-05
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2021-10-26
Last Update Post Date: 2021-10-27
Last Update Post Date Type: ACTUAL